These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16546990)

  • 1. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
    Rice PL; Peters SL; Beard KS; Ahnen DJ
    Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
    Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
    J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites.
    Rice PL; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2004 Nov; 64(22):8148-51. PubMed ID: 15548677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P; Shah PK; Jo H; Lincoln TM
    J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
    Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA
    Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
    Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
    Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.
    Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB
    Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT; Schmidt CM
    Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells.
    Deguchi A; Thompson WJ; Weinstein IB
    Cancer Res; 2004 Jun; 64(11):3966-73. PubMed ID: 15173009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
    Hu Y; Bally M; Dragowska WH; Mayer L
    Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
    Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
    Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
    Moon Y; Yang H; Kim YB
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.
    Thompson WJ; Piazza GA; Li H; Liu L; Fetter J; Zhu B; Sperl G; Ahnen D; Pamukcu R
    Cancer Res; 2000 Jul; 60(13):3338-42. PubMed ID: 10910034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
    Sun Y; Sinicrope FA
    Mol Cancer Ther; 2005 Jan; 4(1):51-9. PubMed ID: 15657353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
    Deguchi A; Xing SW; Shureiqi I; Yang P; Newman RA; Lippman SM; Feinmark SJ; Oehlen B; Weinstein IB
    Cancer Res; 2005 Sep; 65(18):8442-7. PubMed ID: 16166323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
    Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
    Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
    Mhaidat NM; Zhang XD; Jiang CC; Hersey P
    Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.